Hutchison China MediTech Ltd ADR buy melinda
Start price
12.03.18
/
50%
€33.42
Target price
12.09.18
€40.59
Performance (%)
-26.30%
End price
12.09.18
€24.63
Summary
This prediction ended on 12.09.18 with a price of €24.63. The price of Hutchison China MediTech Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.30%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 11.607% | 11.607% | -14.966% | -21.875% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by melinda for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
Pharmazeutische SecteurProduits Agenda 12/03 | 08.00 Uhr veröffentlichte Ergebnisse
Hutchison China Meditech wendet sich an die erste Arzneimittelzulassung in diesem Jahr
(Laufzeit überschritten)


